Andrew Tam, M.D., M.S.
Radiation Oncology
Assistant Clinical Professor, Department of Radiation Oncology
Andrew Tam, M.D., M.S., is an assistant professor of radiation oncology at City of Hope® Arcadia, where he works closely with patients and their cancer care teams to provide accurate, timely diagnoses for a wide range of cancer types using leading-edge imaging procedures.
Dr. Tam, a long-time advocate for greater health care equity, is committed to providing compassionate, evidence-based care to patients regardless of their background or circumstances. His philosophy is founded on empathy, empowerment and equity. He is also passionate about understanding the emotional, psychological and social dimensions that shape patient experiences and has conducted research in this field.
After earning his medical degree at the University of California, San Francisco, Dr. Tam completed his internship in internal medicine at California Pacific Medical Center in the same city, followed by a residency in radiation oncology at City of Hope. He has extensive experience collaborating with international partners in the field of global health, including participating in medical projects and initiatives in Thailand, Ecuador, Honduras and Ethiopia.
Location
Arcadia
Suite 400
Arcadia, CA 91007
Education & Experience
Degrees
- 2015–2020, Doctor of Medicine, University of California, San Francisco, San Francisco, CA
- 2010–2011, Master of Science, Global Health Sciences, University of California, San Francisco, San Francisco, CA
- 2006–2010, Bachelor of Arts, Psychology and Integrative Biology, Minor, Global Poverty and Practice, University of California, Berkeley, Berkeley, CA
Internship
- 2020–2021, Internal Medicine, California Pacific Medical Center, San Francisco, CA
Residency
- 2021–2025, Radiation Oncology, City of Hope, Duarte, CA
Professional Experience
- 2025–Present, Assistant Clinical Professor, Department of Radiation Oncology, City of Hope, Arcadia, CA
Awards & Memberships
American Board of Radiology (ABR) – Board-eligible
Medical Physics – Pass (2025)
Radiation and Cancer Biology – Pass (2025)
Medical Board of California (MBC)
Physician and surgeon license: active
Drug Enforcement Administration (DEA)
Prescription license: active
Publications
Tam A, Ladbury C, Kassardjian A, et al: Combined Regional Approach of Talimogene laherparepvec and Radiotherapy in the Treatment of Advanced Melanoma. Cancers 16:1951, 2024
Tam A, Ladbury C, Glaser S, et al: Experience from an Early Exposure Education Program in Radiation Oncology for High School and Undergraduate Students. Practical Radiation Oncology S1879850024001334, 2024
Tam A, Novak J, Ladbury C, et al: Perception and Utilization of Cannabinoids in Patients Undergoing Radiation Treatment: Our Patients Are Curious
Tam A, Mercier B, Thomas R, et al: Moving the Needle Forward in Genomically-Guided Precision Radiation Treatment. Cancer. DOI: 10.3390/cancers15225314
Tam A, Li YR, Williams T: Grade 5 Radiation Necrosis after Whole Brain Radiotherapy. Practicalradonc
Tam A and Li YR: Ignorance is Bliss? A Case of Incidental Discovery of ATM Mutation in Prostate Cancer
Tam A, Eustace N, Kassardjian A, et al: The Emerging Role of Radiotherapy in Oligoprogressive Non-Small Cell Lung Cancer. Surg Oncol Clin N Am 32:497–514, July 2023. PMID: 37182989
Eustace N, Liu J, Ladbury C, Tam A, et al: Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer. Cancers 16:1031, 2024
Tam A, Amini A: Management After an Initial Nononcologic Approach to an HPV+ Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 115:1026, 2023
Vo K, Ladbury C, Tam A, et al: Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted? Head & Neck 45:2079–2086, 2023
Liu J, Ladbury C, Tam A, et al: Current landscape of radiation oncology in esophageal cancer: a narrative review. J Thorac Dis 14:4494–4505, 2022
Ladbury C, Zarinshenas R, Semwal H… Tam A, et al: Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a narrative review. Transl Cancer Res 11:3853–3868, 2022
Ladbury C, Li R, Danesharasteh A..Tam A, et al: Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617. International Journal of Radiation Oncology*Biology*Physics S0360301623005989, July 2023 PMID: 37406826
Bloom J, Anderson J, McComas K…Tam A, et al: Environmentally Sustainable Radiation Oncology: Can We Turn the Tides? [Internet][cited 2023 Jan 30]
Jiang S, Liu Z, Tian Y… Tam A, et al: A Comprehensive Evaluation of ZrC Nanoparticle in Combined Photothermal and Radiation Therapy for Treatment of Triple-Negative Breast Cancer. Front Oncol 11:801352, 2021
Resneck JS, Abrouk M, Steuer M… Tam A, et al. Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. JAMA Dermatol. May 2016. doi:10.1001/jamadermatol.2016.1774.
Wang J, Feng Q, Tam A, Sun T, Zhou P, So S. Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China. BMC Med Educ. 2016;16(1). doi:10.1186/s12909-016-0608-2.
Bhat R, Belardi B, Mori H... Tam A, et al. Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis. Proceedings of the National Academy of Sciences. Published online August 5, 2016:201609135. doi:10.1073/pnas.1609135113
Tam A, Yuan JT, Mauro TM, Dellavalle RP, Arron ST. Mohs Micrographic Surgery in the VHA. https://www.mdedge.com/fedprac/article/158272/dermatology/mohs-micrographic-surgery-vha-full.
Tam A. Medical School Admissions: An LGBTQ Perspective. Acad Med. 2017;92(6):730-731. doi:10.1097/ACM.0000000000001703.
Tam A, Ho J, Sohn A. Challenges of providing treatment and care to men who have sex with men and with HIV/AIDS in Bangkok. Asian Biomed. December 2014. doi:10.5372/1905-7415.0806.358.